Previous / Next

[20120324. Complications of EMR/ESD (79): Bleeding (43) - warfarin (11) surgeon's point of view]

°íÀ§ÇèȯÀÚÀÇ ÀϹÝÀûÀÎ ¼ö¼ú Àü ¿ÍÆĸ° Áߴܹæħ¿¡ ´ëÇÏ¿© ¾î¶² ½ÉÀå surgeonÀÇ ´äº¯ÀÔ´Ï´Ù. ³»½Ã°æ¿¡ ´ëÇÏ¿© 2005³â ASGE guideline¿¡¼­ Á¦½ÃÇÑ °Íº¸´Ù ¾à°£ ³·Àº °­µµÀÇ anticoagulationÀÌÁö¸¸ ÇÕ¸®Àû Á¢±ÙÀ̶ó°í »ý°¢ÇÕ´Ï´Ù.

1. ¼ö¼ú 5ÀÏÀü warfarin Áß´Ü (3.0ÀÌ»ó½Ã 6ÀÏ)

2. ¼ö¼ú 3-4ÀÏ Àü Enoxaparin 40 mg SQ bid

3. High risk½Ã ÁßÁö ´ÙÀ½³¯ºÎÅÍ 1 mg/kg ¶Ç´Â IV heparin (aPTT 55-80 sec)

4. POD1 warfarin º¹¿ë (¼ö¼ú Àü ¿ë·®´ë·Î)

5. ¼ö¼ú ÈÄ 24-48 ½Ã°£ °æ°ú ÈÄ ÇÊ¿ä¿¡ µû¶ó Enoxaparin 30-40mg q 12 hr SQ ¶Ç´Â IV heparin À¯Áö (aPTT 45-60 sec)


[Âü°í ÀÚ·á]

1) EndoTODAY ¿ÍÆĸ°

2) Ç×Ç÷¼ÒÆÇÁ¦ Antiplatelets - ³»½Ã°æ ȤÀº Á¶Á÷°Ë»ç Àü ¾Æ½ºÇǸ°, Ç×Ç÷¼ÒÆÇÁ¦¸¦ ²÷À» °ÍÀΰ¡?

3) »õ·Î¿î Ç×ÀÀ°íÁ¦ New oral anticoagulant (NOAC)

4) Ç×Ç÷¼ÒÆÇÁ¦, Ç×ÀÀ°íÁ¦ Áß´Ü Áöħ (»ï¼º¼­¿ïº´¿ø 2011)

© ÀÏ¿ø³»½Ã°æ±³½Ç ¹Ù¸¥³»½Ã°æ¿¬±¸¼Ò ÀÌÁØÇà